Regulation of osteoclast activity.
Osteoclasts are the primary cell type responsible for bone resorption. This paper reviews many of the known regulators of osteoclast activity, including hormones, cytokines, ions, and arachidonic acid metabolites. Most of the hormones and cytokines that inhibit osteoclast activity act directly on the osteoclasts. In contrast, most of the hormones and cytokines that stimulate osteoclast activity act indirectly through osteoblasts. Particularly interesting in this regard are agents that directly inhibit activity of highly purified osteoclasts yet stimulate activity of osteoclasts that are co-cultured with osteoblasts. Recent studies have demonstrated that the primary mechanism by which bone resorptive agents stimulate osteoclast activity indirectly is likely to be up-regulation of production of osteoclast differentiation factor/osteoprotegerin ligand (ODF/OPGL) by the osteoblasts. In addition to discussing regulators of osteoclast activity per se, this paper also reviews the role of osteoclast apoptosis to limit the extent of bone resorption.
Greenfield
E M
EM
Department of Orthopaedics, Case Western Reserve University, Cleveland, OH 44106-5000, USA. emg3@po.cwru.edu
Bi
Y
Y
Miyauchi
A
A
D000818:Animals; D017209:Apoptosis; D001862:Bone Resorption / Q000209:etiology; D002118:Calcium / Q000494:pharmacology; D002352:Carrier Proteins / Q000502:physiology; D004967:Estrogens / Q000494:pharmacology; D006801:Humans; D015850:Interleukin-6 / Q000494:pharmacology; D008562:Membrane Glycoproteins / Q000502:physiology; D010006:Osteoblasts / Q000187:drug effects; D010010:Osteoclasts / Q000187:drug effects / Q000502:physiology*; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B
D002352:Carrier Proteins; D004967:Estrogens; D015850:Interleukin-6; D008562:Membrane Glycoproteins; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human; D002118:Calcium